Insulin and insulin-like growth factor-I cause vasorelaxation in human vessels in vitro

Coronary Artery Disease

Volumn 11, Issue 1, 2000, Pages 69-76

  Izhar, Uzi ^a   Hasdai, David ^a   Richardson, Darcy M ^a   Cohen, Pinchas ^c   Lerman, Amir ^a,b  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b MAYO CLINIC   (United States)

^c NONE

Author keywords

Endothelium; Insulin; Internal mammary artery; Saphenous vein

Indexed keywords

INSULIN; NITRIC OXIDE; POTASSIUM CHANNEL; POTASSIUM CHLORIDE; SOMATOMEDIN C; TETRYLAMMONIUM;

ADULT; AGED; ARTICLE; BLOOD VESSEL TONE; CORONARY ARTERY BYPASS SURGERY; DRUG EFFECT; FEMALE; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; MAMMARY ARTERY; NON INSULIN DEPENDENT DIABETES MELLITUS; PRIORITY JOURNAL; SAPHENOUS VEIN; VASCULAR ENDOTHELIUM; VASCULAR SMOOTH MUSCLE; VASODILATATION;

DIABETES MELLITUS, TYPE 2; HUMANS; INSULIN; INSULIN-LIKE GROWTH FACTOR I; MAMMARY ARTERIES; NITRIC OXIDE; SAPHENOUS VEIN; VASODILATION;

EID: 0034102312     PISSN: 09546928     EISSN: None     Source Type: Journal    
DOI: 10.1097/00019501-200002000-00012     Document Type: Article

References (42)

1. 1 Sowers JR. Insulin and insulin-like growth factor in normal and pathological cardiovascular physiology. Hypertension 1997; 29:691-699.
2. 2 Elahi D, McAllon-Dyke M, Fukagawa NK. Hemodynamic and metabolic responses to human insulin-like growth factor-1 in men. In: Spencer EM (editor): Modern concepts in insulin like growth factors. New York: Elsevier; 1991. pp. 219-224.
3. 3 Kerm PA, Svoboda ME, Graves D, Eckel RH, Van Wyk JJ. Insulin-like growth factor action and production in adipocytes and endothelial cells from human adipose tissue. Diabetes 1989; 38:710-717.
4. 4 Khosandi MJ, Fagin JA, Giannella-Neto D, Forrester JS, Cercek B. Regulation of insulin-like growth factor 1 and its receptor in rat aorta after balloon denudation: evidence for local activity. J Clin Invest 1992; 90:1926-1931.
5. 5 LeRoith D, Wemer H, Burguera B, Roberts CT, Mulroney S, Haramati A. The insulin-like growth factor family of peptides, binding proteins and receptors: their potential role in tissue regeneration. Adv Exp Med Biol 1992; 321:21-28.
6. 6 Wu H, Jeng YY, Yue C, Chyu KY, Hsueh WA, Chan TM. Endothelial dependent vascular effects of insulin and insulin-like growth factor 1 in the perfused rat mesenteric artery and aortic ring. Diabetes 1994; 43:1027-1032.
7. 7 McNally PG, Lawrence IG, Watt PAC, Hillier C, Burden AC, Thruston H. The effect of insulin on the vascular reactivity of isolated resistance arteries taken from healthy volunteers. Diabetologia 1995; 38:467-473.
8. 8 Sakai K, Imaixumi H, Takeshita A. Infra-arterial infusion of insulin attenuates vasoreactivity in human forearm. Hypertension 1993; 22:67-73.
9. 9 Taddei S, Virdis A, Mattei P, Natali A, Ferrannini E, Salvetti A. Effect of insulin on acetylcholine-induced vasodilation in normotensive subjects and patients with essential hypertension. Circulation 1995; 92:2911-2918.
10. 10 Pieper GM, Meier DA, Hager SR. Endothelial dysfunction in a model of hyperglycemia and hyperinsulinemia. Am J Physiol 1995; 269:H845-H850.
11. 11 Scherrer U, Randin D, Vollenweider L, Nicod P. Nitric oxide release accounts for insulin vascular effects in humans. J Clin Invest 1994; 94:2511-2515.
12. 12 Christiansen JS, Frandsen PA, Svendsen PA, Gammelgaard J, Parving HH. Rapid changes in kidney function: factors influencing kidney function in diabetics and normal man. Acta Endocrinol 1981; 242:11-13.
13. 2 in porcine coronary artery. Circulation 1990; 81:1654-1659.
14. 14 Creager MA, Liang CS, Coffman JD. Beta adrenergic-mediated vasodilator response to insulin in the human forearm. J Pharmacol Exp Ther 1985; 235:709-714.
15. 15 McKay MK, Hester RL. Role of nitric oxide, adenosine, and ATP-sensitive potassium channels in insulin-induced vasodilatation. Hypertension 1996; 28:202-208.
16. 16 Inishi Y, Okuda T, Arakawa T, Kurokawa K. Insulin attenuates intra-cellular calcium responses and cell contraction caused by vasoactive agents. Kidney Int 1994; 45:1318-1325.
17. 17 Copeland KC, Sreekumaran Nair K. Recombinant human insulin-like growth factor-I increases forearm blood flow. J Clin Endocrinol Metab 1994; 79:230-232.
18. 18 Tsukahara H, Gordienko DV, Tonshoff B, Gelato MC, Goligorsky MS. Direct demonstration of insulin-like growth factor-I-induced nitric oxide production by endothelial cells. Kidney Int 1994; 45:598-604.
19. 19 Prosser CG, Fleet IR, Corps AN, Froesch ER, Heap RB. Increase in milk secretion and mammary blood flow by infra-arterial infusion of insulin-like growth factor-I into the mammary gland of the goat. J Endocrinol 1990; 126:437-443.
20. 20 Walsh MF, Barazi M, Pete G, Muniyappa R, Dunbar JC, Sowers JR. Insulin-like growth factor-I diminishes in vivo and in vitro vascular contractility: role of vascular nitric oxide. Endocrinology 1996; 137:1798-1803.
21. 21 Juncos LA, Ito S. Disparate effects of insulin on isolated rabbit afferent and efferent arterioles. J Clin Invest 1990; 81:1654-1659.
22. 22 Baron AD, Steinberg HO. Vascular actions of insulin in health and disease. In: Sowers JR (editor): Endocrinology of the vasculature. Totowa NJ: Humana Press Inc.; 1996. pp. 95-107.
23. 23 Yagi S, Takata S, Kiyokawa H, Yamamoto M, Noto Y, Ikeda T, et al. Effects of insulin on vasoconstrictive responses to norepinephrine and angiotensin II in rabbit femoral artery and vein. Diabetes 1988; 37:1064-1067.
24. 24 Townsend RR, Yamamoto R, Nickols M, DiPette DJ, Nickolas GA. Insulin enhances pressor responses to norepinephrine in rat mesenteric vasculature. Hypertension 1992; 19 (suppl 11):II105-II110.
25. 25 Hasdai D, Rizza RA, Holmes DR, Richardson DM, Cohen P, Lerman A. Insulin and insulin-like growth factor-1 cause coronary vasorelaxation in vitro. Hypertension 1998; 32:228-234.
26. 26 Luscher TF, Diederich D, Siebernmann R, Lehmann K, Stulz P, von Segesser L, et al. Difference between endothelium-dependent relaxation in arterial and in venous coronary bypass grafts. N Engl J Med 1988; 319:462-467.
27. 27 Sowers JR. Effects of insulin and IGF-I on vascular smooth muscle glucose and cation metabolism. Diabetes 1996; 45:47-51.
28. 28 Hirschberg R, Brunori G, Koppel J, Guler HP. Effects of insulin-like growth factor I on renal function in normal men. Kidney Int 1993; 43:387-397.
29. 29 Hu Y, Pete G, Walsh M, Sowers JR, Dunbar JC. Central IGF-I decreases systemic blood pressure and increases blood flow in selective vascular beds. Horm Metab Res. 1996; 28:211-214
30. 30 Loop FD, Lytle BW, Cosgrove DM, Stewart RW, Goormastic M, Williams GW, et al. Influence of the internal mammary artery graft on 10-year survival and other cardiac events. N Engl J Med 1986; 314:1-6.
31. 31 Cameron A, Davis KB, Green G, Schaff HV. Coronary bypass surgery with internal thoracic artery grafts effects on survival over 15-year period. N Engl J Med 1996, 334:216-219.
32. 32 Thom S, Sever PS. Endothelium-dependent relaxations in human arteries and veins. Clin Sci 1987; 73:547-552.
33. 33 Luscher TF, Yang Z, Tschudi M, von Segesser L, Stulz P, Boulanger C, et al. Interaction between endothelin-I and endothelium-derived relaxing factor in human arteries and veins. Circulation 1990; 66:1088-1094.
34. 34 Steinberg HO, Brechtel G, Johnson A, Fineberg N, Baron DB. Insulin-mediated skeletal muscle vasodilation is nitric oxide dependent-a novel action of insulin to increase nitric oxide release. J Clin Invest 1994; 1172-1179.
35. 35 Muniyappa R, Walsh MF, Ranji JS, Zayas RM, Standley PR, Ram JL, et al. Insulin-like growth factor-I increases vascular smooth muscle nitric oxide production. Life Sci 1997; 61:925-931.
36. 36 Anderson EA, Mark AL. The vasodilator actions of insulin: implications for the insulin hypothesis of hypertension. Hypertension 1993; 21:136-141.
37. 37 Nelson MT, Quayle JM. Physiological roles and properties of potassium channels in arterial smooth muscle. Am J Physiol. 1995; 268:C799-C822.
38. 38 Szentivanyi M Jr, Berczi V, Huttl T, Reneman RS, Monos E. Venous myogenic tone and its regulation through potassium channels depends on chronic intravascular pressure. Circ Res 1997; 81;988-995.
39. 39 Luu TN, Dashwood MR, Tadjkarimi S, Chester AH, Yacoub MH. ATP-sensitive potassium channels mediate vasodilatation produced by calcitonin gene-related peptid in human internal mammary but not gastroepiploic arteries. Eur J Clin Inves 1997; 27:960-966.
40. 40 Ferrannini E, Buzzigoli G, Bonadonna R, Giorico MA, Oleggini M, Graziadei L, et al. Insulin resistance in essential hypertension. N Engl J Med 1987; 317:350-357.
41. 41 Steinberg HO, Chaker H, Learning R, Johnson A, Brechtel G, Baron AD. Obesity/insulin resistance is associated with endothelial dysfunction. Implication for the syndrome of insulin resistance. J Clin Invest 1996; 97:2601-2610.
42. 42 McVeigh GE, Brennan GM, Johnston GD, McDermott BJ, McGrath LT, Henry WR, et al. Impaired endothelium dependent and independent vasodilation in patients with type 2 diabetes mellitus. Diabetologica 1992; 35:771-776.